CEO SUMMARY: All signs point to a potentially dismal financial outcome for the clinical lab testing industry as Congress tries to trim spending by $1.2 trillion over the next 10 years. At least three proposals to significantly cut lab test reimbursement are in active debate by federal lawmakers. One proposal calls for reinstituting the Medicare […]
Congress Likely to Pass Deep Cuts in Lab Test Fees
Reinstituting Medicare patient co-pay is one of three proposals to cut lab test reimbursement
- By Robert Michel
- > From the Volume XVIII No. 14 - October 17, 2011 Issue
- Tags: accountable care, accountable care act, acla, affordable care act, american clinical lab, american clinical laboratory, cap, clia, clinical lab, clinical lab fee schedule, clinical lab test, clinical lab testing, clinical laboratories, Clinical Laboratory, clinical labs, dark report, DarkDaily, health reform, healthcare reform, hie, impac, lab administrator, lab fees, lab industry, lab staff, lab test, lab testing, laboratories, laboratory association, laboratory test, laboratory tests, ldt, Medicare, Medicare Part B, molecular tests, national independent laboratory association, NY labs, pathologists, Pathology group, the affordable care act, the dark report
